1. The role of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 in esophageal squamous cell carcinoma
   Junhui Bao et al, 2020, Medicine CrossRef
2. Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer
   Javad Alizadeh et al, 2023, Cancers CrossRef
3. mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival
   Yonghuai Feng et al, 2017, Biochemical and Biophysical Research Communications CrossRef
4. Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer
   Yang Zhao et al, 2021, Frontiers in Oncology CrossRef
5. Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy
   Xuan Ni et al, 2024, Acta Pharmacologica Sinica CrossRef
6. The Expression of Two Distinct Sets of Glycolytic Enzymes Reveals Differential Effects of Glycolytic Reprogramming on Pancreatic Ductal Tumorigenesis in Mice
   Yannan Zhang et al, 2023, Biomedicines CrossRef
7. Endothelial cell metabolism: an update anno 2017
   Laure-Anne Teuwen et al, 2017, Current Opinion in Hematology CrossRef
8. Assessing the anticancer effects associated with food products and/or nutraceuticals using in vitro and in vivo preclinical development-related pharmacological tests
   Florence Lefranc et al, 2017, Seminars in Cancer Biology CrossRef
9. PFKFB3 in neovascular eye disease: unraveling mechanisms and exploring therapeutic strategies
   Peiyu Liu et al, 2024, Cell & Bioscience CrossRef
10. PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis
    Fang Peng et al, 2018, International Journal of Oncology CrossRef
11. Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells
    Chen Guo et al, 2019, Cancer Cell International CrossRef
12. Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
    Mathijs P. Scholtes et al, 2021, Cancers CrossRef
13. Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets
    Krzysztof Kotowski et al, 2021, Cancers CrossRef
14. Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review
    Ana Silva et al, 2023, International Journal of Molecular Sciences CrossRef
15. Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial Bladder Cancer
    Ana Silva et al, 2023, Pharmaceutics CrossRef
16. In Vivo Anticancer Activity of AZD3965: A Systematic Review
    Ana Silva et al, 2021, Molecules CrossRef
17. Lactate-upregulated NADPH-dependent NOX4 expression via HCAR1/PI3K pathway contributes to ROS-induced osteoarthritis chondrocyte damage
    Yi-Fan Huang et al, 2023, Redox Biology CrossRef
18. Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect
    Julieta Afonso et al, 2024, Cancers CrossRef
19. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
    Julieta Afonso et al, 2020, Nature Reviews Urology CrossRef
20. Current Development and Application of Anaerobic Glycolytic Enzymes in Urothelial Cancer
    Yi-Fang Yang et al, 2021, International Journal of Molecular Sciences CrossRef
21. Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells
    Selami Demirci et al, 2018, Molecular and Cellular Biochemistry CrossRef
22. Flavonoid-based nanomedicines to target tumor microenvironment
    Wamidh H. Talib et al, 2022, OpenNano CrossRef
23. PFK15, a PFKFB3 antagonist, inhibits autophagy and proliferation in rhabdomyosarcoma cells
    Chunhui Wang et al, 2018, International Journal of Molecular Medicine CrossRef